NCT06049745View on ClinicalTrials.gov

Use of Misoprostol in Hysteroscopic Myomectomy

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

October 31, 2026

Conditions

Hysteroscopic Myomectomy

Interventions

DRUG

Misoprostol 400 Microgram Oral Tablet

S.L misoprostol 400 mcg

Trial Locations (1)

Unknown

Assuta Ashdod University Hospital, Ashdod

Sponsors

Collaborators (1)

Assuta Medical Center

All Listed Sponsors

collaborator

Assuta Medical Center

OTHER

lead

Assuta Ashdod Hospital

OTHER